Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Background/Aims The global proportion of hepatocellular carcinoma (HCC) attributable to metabolic dysfunction-associated fatty liver disease (MAFLD) is unclear. The MAFLD diagnostic criteria allows objective diagnosis in the presence of steatosis plus defined markers of metabolic dysfunction, irresp...

Cijeli opis

Bibliografski detalji

Glavni autori:	Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone I Strasser, Jacob George
Format:	Artigo
Jezik:	Inglês
Izdano:	Korean Association for the Study of the Liver 2024-07-01
Serija:	Clinical and Molecular Hepatology
Teme:	fatty liver hepatocellular carcinoma epidemiology prevalence metabolic syndrome
Online pristup:	http://e-cmh.org/upload/pdf/cmh-2024-0109.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!